Literature DB >> 1211910

Pharmacokinetics of minocycline in renal failure.

P G Welling, W R Shaw, S J Uman, F L Tse, W A Craig.   

Abstract

The pharmacokinetics of minocycline have been studied after single intravenous infusions and repeated oral doses to human subjects with varying degrees of renal impairment. There was no evidence of reduced drug clearance with reduced renal function after intravenous doses although there appeared to be an increase in the tissue distribution of antibiotic in the body in uremia. After identical multiple oral dosage regimens serum levels of antibiotic were comparable in normal and mildly uremic subjects. There was no evidence of renal toxicity in normal or uremic subjects with the repeated dosage regimen used.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1211910      PMCID: PMC429414          DOI: 10.1128/AAC.8.5.532

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  16 in total

1.  Renal disease and the metabolic effects of tetracycline.

Authors:  M E SHILS
Journal:  Ann Intern Med       Date:  1963-03       Impact factor: 25.391

2.  Doxycycline: studies in normal subjects and patients with renal failure.

Authors:  P Lee; E R Crutch; R B Morrison
Journal:  N Z Med J       Date:  1972-06

3.  Drug distribution and renal failure.

Authors:  M Gibaldi; D Perrier
Journal:  J Clin Pharmacol New Drugs       Date:  1972 May-Jun

4.  Susceptibility of common pathogenic bacteria to seven tetracycline antibiotics in vitro.

Authors:  N H Steigbigel; C W Reed; M Finland
Journal:  Am J Med Sci       Date:  1968-03       Impact factor: 2.378

5.  Pharmacokinetic studies on minocycline in man.

Authors:  H Macdonald; R G Kelly; E S Allen; J F Noble; L A Kanegis
Journal:  Clin Pharmacol Ther       Date:  1973 Sep-Oct       Impact factor: 6.875

6.  Pharmacokinetics of cefazolin in normal and uremic subjects.

Authors:  P G Welling; W A Craig; A L Gordon; C M Kunin
Journal:  Clin Pharmacol Ther       Date:  1974-04       Impact factor: 6.875

7.  Tetracyclines and renal failure.

Authors:  P J Little; R R Bailey
Journal:  N Z Med J       Date:  1970-09

8.  Tetracycline toxicity in renal failure.

Authors:  C R George; R A Evans
Journal:  Med J Aust       Date:  1971-06-12       Impact factor: 7.738

9.  Influence of repetitive dosing of tetracyclines on biologic half-life in serum.

Authors:  J T Doluisio; L W Dittert
Journal:  Clin Pharmacol Ther       Date:  1969 Sep-Oct       Impact factor: 6.875

10.  Antibacterial activity in mice of minocycline, a new tetracycline.

Authors:  G S Redin
Journal:  Antimicrob Agents Chemother (Bethesda)       Date:  1966
View more
  16 in total

1.  Pharmacodynamics of Minocycline against Acinetobacter baumannii in a Rat Pneumonia Model.

Authors:  Ziad Tarazi; Mojgan Sabet; Michael N Dudley; David C Griffith
Journal:  Antimicrob Agents Chemother       Date:  2019-01-29       Impact factor: 5.191

2.  Simulated antibiotic exposures in an in vitro hollow-fiber infection model influence toxin gene expression and production in community-associated methicillin-resistant Staphylococcus aureus strain MW2.

Authors:  Solen Pichereau; Madhulatha Pantrangi; William Couet; Cedric Badiou; Gerard Lina; Sanjay K Shukla; Warren E Rose
Journal:  Antimicrob Agents Chemother       Date:  2011-11-07       Impact factor: 5.191

Review 3.  Protein binding of antimicrobials: clinical pharmacokinetic and therapeutic implications.

Authors:  W A Craig; P G Welling
Journal:  Clin Pharmacokinet       Date:  1977 Jul-Aug       Impact factor: 6.447

4.  Netilmicin pharmacokinetics after single intravenous doses to elderly male patients.

Authors:  P G Welling; A Baumueller; C C Lau; P O Madsen
Journal:  Antimicrob Agents Chemother       Date:  1977-09       Impact factor: 5.191

Review 5.  Drug prescribing in renal failure.

Authors:  W M Bennett
Journal:  Drugs       Date:  1979-02       Impact factor: 9.546

6.  In vitro activity of three tetracycline antibiotics against Acinetobacter calcoaceticus subsp. anitratus.

Authors:  J V Crues; B E Murray; R C Moellering
Journal:  Antimicrob Agents Chemother       Date:  1979-11       Impact factor: 5.191

7.  One-dose and multiple-dose kinetics of minocycline in patients with renal disease.

Authors:  I Sklenar; P Spring; L Dettli
Journal:  Agents Actions       Date:  1977-09

8.  Minocycline to improve neurologic outcome in stroke (MINOS): a dose-finding study.

Authors:  Susan C Fagan; Jennifer L Waller; Fenwick T Nichols; David J Edwards; L Creed Pettigrew; Wayne M Clark; Christiana E Hall; Jeffrey A Switzer; Adviye Ergul; David C Hess
Journal:  Stroke       Date:  2010-08-12       Impact factor: 7.914

9.  Differences in kinetic properties of drugs: implications as to the selection of a particular drug for use in patients with renal failure with special emphasis on antibiotics and beta-adrenoceptor blocking agents.

Authors:  J Fabre; H M Fox; P Dayer; L Balant
Journal:  Clin Pharmacokinet       Date:  1980 Sep-Oct       Impact factor: 6.447

10.  Pharmacokinetic and Pharmacodynamic Profiling of Minocycline for Injection following a Single Infusion in Critically Ill Adults in a Phase IV Open-Label Multicenter Study (ACUMIN).

Authors:  Thomas P Lodise; Scott Van Wart; Zoe M Sund; Adam M Bressler; Akram Khan; Amy T Makley; Yasir Hamad; Robert A Salata; Fernanda P Silveira; Matthew D Sims; Badih A Kabchi; Mohamed A Saad; Carrie Brown; Randolph E Oler; Vance Fowler; Richard G Wunderink
Journal:  Antimicrob Agents Chemother       Date:  2021-02-17       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.